Services

An over 35 year experience has allowed the Valpharma Group to obtain brilliant results such as:

• various patents to support its own technologies;
• the development of over 300 drug products in modified release oral dosage form;
• a conspicuous presence on the market of the pharmaceutically most advanced countries, in collaboration with major pharmaceutical companies, including multinationals;

As pharmaceutical contract manufacturers, both plants in Italy and Republic of San Marino are duly authorized by the Italian Health Authorities AIFA (for Valpharma International S.p.A. with Decree no. aM-15/2011 dated 26th January 2011 and for Valpharma S.p.A. with Protocol no. AIFA/UAO/29933/P/I.5.i.a.6 dated 22nd March 2011).


During more than 35 years collaboration together with the most important pharmaceutial companies all over the world, Valpharma realized with success, the following pharmaceutical formulations:


Sustained Release
Modified Release
Pulsatil Release
Chrono Release
Targeted Delivery
Multiparticulate formulations
Matrix tablets
Multilayer tablets
MUPS (Multi Unit Pellets System)
Orally disintegrating tablets
Co-precipitation
Bioavailability Enhancement